Antibodies are the memory cells that help humans enhance their defences when exposed to the same virus in the future. They are proteins created by our immune system as a defence mechanism after we are infected or vaccinated.
QIAGEN receives U.S. FDA Emergency Use Authorization for fast and easy-to-use digital test to detect SARS-CoV-2 coronavirus antibodies
Product News: QIAGEN receives U.S. FDA Emergency Use Authorization for fast and easy-to-use digital test to detect SARS-CoV-2 coronavirus antibodies
21 May 2021
QIAGEN has announced it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the fast and easy-to-use QIAreach
® Anti-SARS-CoV-2 Total Test.
The authorization means QIAGEN can start making its portable antibody testing device available to health-care professionals in the U.S. Each antibody test takes only about 10 minutes to identify whether a person carries antibodies to the SARS-CoV-2 virus as a result of prior infection. Individual test results are read on a digital eHub device that can process up to 32 tests per hour – and will eventually also run the antigen test.
Among the most promising therapeutic options for individuals with coronavirus disease 2019 (COVID-19) are monoclonal antibodies (mAbs). In this study, Jones et al . identified, characterized, and tested one such mAb, LY-CoV555, in vitro and in vivo. They found that LY-CoV555 bound to the severe acute respiratory distress syndrome coronavirus-2 (SARS-CoV-2) spike protein and prevented its interaction with angiotensin-converting enzyme 2. Prophylactic treatment with LY-CoV555 protected the upper and lower respiratory tracts of nonhuman primates from becoming infected with SARS-CoV-2. Together, these data support the clinical use of LY-CoV555 for treating patients with COVID-19.
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) poses a public health threat for which preventive and therapeutic agents are urgently needed. Neutralizing antibodies are a key class of therapeutics that may bridge widespread vaccination campaigns and offer a treatment solution in populations less res
Northwestern Now
Dedre Gentner, Thomas McDade and Michael R. Wasielewski recognized for achievements in original research
Three faculty members of Weinberg College of Arts and Sciences at Northwestern psychologist Dedre Gentner, biological anthropologist Thomas McDade and chemist Michael R. Wasielewski have been elected to the prestigious National Academy of Sciences. Membership in the academy is one of the highest honors given to a scientist in the United States.
Gentner, McDade and Wasielewski are among 120 new members and 30 international members selected in recognition of their distinguished and continuing achievements in original research. They will be inducted at the academy’s annual meeting next year.